Combinent Biomedical Systems is an emerging specialty pharmaceutical company based in Lexington, Massachusetts. They focus on developing novel drug combinations and formulations using their proprietary transvaginal drug delivery system. Their products target women's reproductive endocrinology disorders, as well as diabetes, obesity, and infectious diseases. Incorporated in 2000, Combinent Biomedical Systems aims to deliver hydrophobic and hydrophilic molecules, proteins, and other large molecules through their multi-segmented vaginal rings.